1.1 List of Tables 9
1.2 List of Figures 10
2 Introduction 11
2.1 What Is This Report About? 11
3 Definitions of the Markets/Categories Covered 12
3.1 In Vitro Diagnostics 12
3.1.1 Blood Test Reagents 12
3.1.2 Microbiology Test Reagents 12
4 Company Snapshot 13
4.1 Key Information 13
4.2 Company Overview 13
4.3 Financial Performance 13
4.4 SWOT Snapshot 13
5 Business Description 14
5.1 Business Overview 14
5.2 Clinical Diagnostics and Blood Screening products 14
5.2.1 Overview 14
5.2.2 Financials 14
5.2.3 Market View 14
5.2.4 Key Strategies 15
5.3 Major Products and Services 15
5.3.1 Overview 15
6 History 17
7 Business Strategy 21
7.1 Mission Statement 21
7.2 Strategy 21
7.3 Corporate Social Responsibility 21
7.3.1 Overview 21
8 Value Chain Analysis 22
8.1 Manufacturing 22
8.1.1 In House Manufacturing 22
8.1.2 Outsourcing 23
8.2 Product Development 23
8.2.1 Regulatory Approvals 23
8.2.2 Clinical Trials 23
8.2.3 Research and Development 23
8.3 Sales and Marketing 24
8.3.1 Partnerships and Alliances 24
8.3.2 Licensing Agreements 24
9 SWOT Analysis 25
9.1 Overview 25
9.2 Gen-Probe Incorporated Strengths 25
9.2.1 Core technologies 25
9.2.2 Constant financial growth 26
9.2.3 Research and development activities 26
9.3 Gen-Probe Incorporated Weaknesses 26
9.3.1 High focus on North America 26
9.3.2 Product recalls 27
9.3.3 Single third party manufacturers 27
9.4 Gen-Probe Incorporated Opportunities 27
9.4.1 Wide range of FDA approved products 27
9.4.2 Awards 27
9.5 Gen-Probe Incorporated Threats 28
9.5.1 Limited manufacturing facilities 28
9.5.2 Use of biological and harmful materials 28
9.5.3 Implementation problem of information technology systems 28
10 Competitors 29
11 Gen-Probe Incorporated Medical Equipment Market Share Analysis 30
11.1 Gen-Probe Incorporated, Global, Market Share (2007) 30
11.2 Gen-Probe Incorporated, APAC, Market Share (2007) 31
11.3 Gen-Probe Incorporated, Europe, Market Share (2007) 32
11.4 Gen-Probe Incorporated, MEA, Market Share (2007) 33
11.5 Gen-Probe Incorporated, North America, Market Share (2007) 34
11.6 Gen-Probe Incorporated, SCA, Market Share (2007) 35
12 Gen-Probe Incorporated Medical Equipment Market Share Analysis by Category 36
12.1 Gen-Probe Incorporated, In Vitro Diagnostics by Category, Global, Market Share (2007) 36
12.2 Gen-Probe Incorporated, In Vitro Diagnostics by Category, APAC, Market Share (2007) 38
12.3 Gen-Probe Incorporated, In Vitro Diagnostics by Category, Europe, Market Share (2007) 39
12.4 Gen-Probe Incorporated, In Vitro Diagnostics by Category, MEA, Market Share (2007) 40
12.5 Gen-Probe Incorporated, In Vitro Diagnostics by Category, North America, Market Share (2007) 41
12.6 Gen-Probe Incorporated, In Vitro Diagnostics by Category, SCA, Market Share (2007) 42
13 Revenue Analysis 43
13.1 Revenue by Segment 43
13.2 Revenue by Geography 43
14 Financial and Operational Review 44
14.1 Financial Statements 44
14.2 Financial Ratios 45
15 Share Holding Structure 46
16 Key Employees 47
17 Key Employee Biographies 48
18 Company Statement 50
19 Locations And Subsidiaries 55
19.1 Head Office 55
20 Financial Deals Landscape 56
20.1 Acquisition 56
20.1.1 Gen-Probe Acquires Stake In Qualigen 56
20.1.2 Gen-Probe to Acquire Innogenetics 57
20.1.3 Xceed Molecular Enters Into Licensing Agreement with Gen-Probe 59
20.1.4 Millipore Signs an Agreement with Gen-Probe 61
20.1.5 Gen-Probe Signs an Agreement with 3M Company 62
20.1.6 Gen-Probe Signs an Agreement with 3M 64
20.1.7 Gen-Probe Signs an Agreement with Alnylam Pharmaceuticals 65
20.1.8 Gen-Probe Signs an Agreement with Molecular Profiling Institute 67
20.1.9 Gen-Probe Signs an Agreement with Millipore 68
20.1.10 bioMerieux Signs An Agreement With Gen-Probe 70
20.1.11 bioMerieux Signs An Agreement With Gen-Probe 71
21 Recent Developments 73
21.1 Strategy and Business Planning 73
21.1.1 Jun 17, 2008: 3M Ends Staph-Screening Partnership with Gen-Probe 73
21.1.2 Apr 30, 2007: Gen-Probe And 3M Collaborate To Develop Rapid Molecular Tests 73
21.2 Financial Announcements 73
21.2.1 Jul 31, 2008: Gen-Probe Declares 2Q 2008 Results 73
21.2.2 Apr 28, 2008: Gen-Probe Declares Q1 2008 Results 75
21.2.3 Apr 10, 2008: Gen-Probe to Declare Q1 2008 Results 77
21.2.4 Oct 30, 2007: Gen-Probe Reports Q3 2007 Results 77
21.2.5 Aug 01, 2007: Gen-Probe Declares Q2 2007 Results 79
21.2.6 May 01, 2007: Gen-Probe Declares Q1 2007 Results 81
21.2.7 Feb 13, 2007: Gen-Probe Declares Q4 2006 Results 83
21.2.8 Feb 13, 2007: Gen-Probe Declares Q4 2007 Results 85
21.3 Other Significant Developments 87
21.3.1 May 19, 2008: Gen-Probe Elects New Board Member 87
21.3.2 Feb 11, 2008: Gen-Probe Appoints President 87
21.3.3 Feb 11, 2008: Gen-Probe Appoints COO 88
21.3.4 Nov 19, 2007: Gen-Probe Appoints VP, Operations 88
21.3.5 Sep 20, 2007: Gen-Probe Elects New Board Member 88
21.3.6 Feb 13, 2007: Gen-Probe COO To Join 88
22 Gen-Probe Incorporated Pipeline Products 89
22.1 APTIMA HPV Assay 89
22.1.1 Product Overview 89
22.1.2 Product Description 89
22.1.3 Product Status 89
22.1.4 Clinical Trials 89
22.1.5 Product Milestone 90
22.2 PROGENSA PCA3 Assay 90
22.2.1 Product Overview 90
22.2.2 Product Description 90
22.2.3 Product Status 91
22.2.4 Clinical Trials 91
22.2.5 Product Milestone 92
22.3 Panther System 92
22.3.1 Product Overview 92
22.3.2 Product Description 92
22.3.3 Product Status 93
22.4 Methicillin-resistant Staphylococcus aureus nucleic acid test 93
22.4.1 Product Overview 93
22.4.2 Product Description 93
22.4.3 Product Status 93
22.4.4 Product Milestone 94
23 Appendix 95
23.1 Global Markets Direct Research Methodology 95
23.2 Coverage 96
23.3 Secondary Research 96
23.4 Primary Research 97
23.5 Models 97
23.6 Forecasts 98
23.7 Expert Panels 98
23.8 Market Revenue Chapters 98
23.8.1 Abbreviations 98
23.8.2 Currency Conversions 99
23.9 About Global Markets Direct 100
23.10 Contact Us 100
23.11 Disclaimer 100
[Fade out table of contents]
